Journal article · 2021

A Tumor‐Penetrating Nanomedicine Improves the Chemoimmunotherapy of Pancreatic Cancer

Qi‐Song Tong, Wei‐Min Miao, Hua Huang, Jia‐Qi Luo, Rong Liu, Yong‐Cong Huang, Dong‐Kun Zhao, Song Shen, Jin‐Zhi Du, Jun Wang

Small, 17(29), e2101208 · Published 18 June 2021 · DOI 10.1002/smll.202101208

View at the publisherCite this paper

In brief

“A Tumor‐Penetrating Nanomedicine Improves the Chemoimmunotherapy of Pancreatic Cancer” is a 2021 journal article by Qi‐Song Tong and 9 co-authors, published in Small. OpenAlex counts 43 citations as of 21 November 2026, which puts it in the top 4% of works published in 2021 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
43
Most cited in
2022 (12)
Field-weighted impact
1.74
References
61
Authors
10

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is one of the most malignant tumors with a low survival rate. The therapeutic effect of chemotherapy and immunotherapy for PDAC is disappointing due to the presence of dense tumor stroma and immunosuppressive cells in the tumor microenvironment (TME). Herein, a tumor-penetrating nanoparticle is reported to modulate the deep microenvironment of… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Tong, Q., Miao, W., Huang, H., Luo, J., Liu, R., Huang, Y., Zhao, D., Shen, S., Du, J., & Wang, J. (2021). A Tumor‐Penetrating Nanomedicine Improves the Chemoimmunotherapy of Pancreatic Cancer. Small, 17(29), e2101208. https://doi.org/10.1002/smll.202101208

MLA 9

Tong, Qi‐Song, et al. “A Tumor‐Penetrating Nanomedicine Improves the Chemoimmunotherapy of Pancreatic Cancer.” Small, vol. 17, no. 29, 2021, p. e2101208. https://doi.org/10.1002/smll.202101208.

Chicago

Tong, Qi‐Song, Wei‐Min Miao, Hua Huang, Jia‐Qi Luo, Rong Liu, Yong‐Cong Huang, Dong‐Kun Zhao, Song Shen, Jin‐Zhi Du, and Jun Wang. 2021. “A Tumor‐Penetrating Nanomedicine Improves the Chemoimmunotherapy of Pancreatic Cancer.” Small 17 (29): e2101208. https://doi.org/10.1002/smll.202101208.

Harvard

Tong, Q. et al. (2021) ‘A Tumor‐Penetrating Nanomedicine Improves the Chemoimmunotherapy of Pancreatic Cancer’, Small, 17(29), p. e2101208. doi:10.1002/smll.202101208.

IEEE

Q. Tong et al., “A Tumor‐Penetrating Nanomedicine Improves the Chemoimmunotherapy of Pancreatic Cancer,” Small, vol. 17, no. 29, p. e2101208, 2021, doi: 10.1002/smll.202101208.

BibTeX

@article{tong2021tumor,
  title     = {{A Tumor‐Penetrating Nanomedicine Improves the Chemoimmunotherapy of Pancreatic Cancer}},
  author    = {Tong, Qi‐Song and Miao, Wei‐Min and Huang, Hua and Luo, Jia‐Qi and Liu, Rong and Huang, Yong‐Cong and Zhao, Dong‐Kun and Shen, Song and Du, Jin‐Zhi and Wang, Jun},
  journal   = {Small},
  year      = {2021},
  volume    = {17},
  number    = {29},
  pages     = {e2101208},
  doi       = {10.1002/smll.202101208},
  url       = {https://doi.org/10.1002/smll.202101208}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20221212
20231111
202488
202599
202633

Its field-weighted citation impact is 1.74: it has been cited 1.74 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery

  • pancreatic ductal adenocarcinoma
  • chemoimmunotherapy
  • gemcitabine prodrug
  • pH-responsive polymers
  • PAMAM dendrimers
  • tumor microenvironment
  • tumor-associated macrophages
  • myeloid-derived suppressor cells

Work with this paper

Most-cited papers in Materials Science

All highly cited Materials Science papers

Questions about this paper

How do I cite this paper in APA style?

Tong, Q., Miao, W., Huang, H., Luo, J., Liu, R., Huang, Y., Zhao, D., Shen, S., Du, J., & Wang, J. (2021). A Tumor‐Penetrating Nanomedicine Improves the Chemoimmunotherapy of Pancreatic Cancer. Small, 17(29), e2101208. https://doi.org/10.1002/smll.202101208

How many times has this paper been cited?

43 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Qi‐Song Tong, Wei‐Min Miao, Hua Huang, Jia‐Qi Luo, Rong Liu, Yong‐Cong Huang, Dong‐Kun Zhao, Song Shen, Jin‐Zhi Du, Jun Wang.

What is the DOI of this paper?

10.1002/smll.202101208, permanently at https://doi.org/10.1002/smll.202101208. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.